Pain is a common issue that is present in cancer survivors as well as those with active malignant processes. Despite opioid analgesics and adjuvant therapies such as systemic corticosteroids, many patients have persistent localized pain. We describe a case series of 3 cancer patients who have concurrent hip- and greater trochanteric–related pain. We performed a single-insertion-site, ultrasound-guided injection to target both the intra-articular hip and greater trochanteric bursa for each patient. All patients reported an improvement in pain symptoms and function with no major complications. Targeted corticosteroid injections provide a potential for relief of malignant joint pain.
From the *Department of Rehabilitation and Regenerative Medicine, NewYork-Presbyterian Hospital - University Hospital of Columbia and Cornell, New York, New York
†Weill Cornell Tri-Institutional Pain Medicine Program, Department of Anesthesiology, Weill Cornell Medicine, New York, New York
‡Department of Anesthesiology and Critical Care, Memorial Sloan Kettering Cancer Center, New York, New York.
Accepted for publication December 31, 2018.
Conflicts of Interest: See Disclosures at the end of the article.
Address correspondence to Amitabh Gulati, MD, Department of Anesthesiology and Critical Care, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065. Address e-mail to email@example.com.